Vincenzo Bramanti

Dr. Vincenzo Bramanti

A.S.P. RAGUSA, Ragusa, Sicilia, Italy
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
CGCesarina Giallongo
Cesarina Giallongo
Daniele TibulloDaniele Tibullo
Daniele Tibullo
NPNunziatina L. Parrinello
Nunziatina L. Parrinello
PCPiera La Cava
Piera La Cava
Michelino Di RosaMichelino Di Rosa
Michelino Di Rosa
FRFrancesco Di Raimondo
Francesco Di Raimondo
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)

31 December 2013 in Current Alzheimer Research
Verified
Journal Article
Closed access
PDF file
ETEnea Traini
Enea Traini
Vincenzo BramantiVincenzo Bramanti
Vincenzo Bramanti
Francesco AmentaFrancesco Amenta
Francesco Amenta
Cholinergic precursors have represented the first approach to counter cognitive impairment occurring in adultonset dementia disorders. These compounds were early leaved because their clinical efficacy was not clearly demonstrated. This is probably not true for some choline-containing phospholipids including choline alphoscerate. Choline alphoscerate increases the release of acetylcholine in rat hippocampus, facilitates learning and memory in experimental animals, improves brain transduction mechanisms and decreases age-dependent structural changes occurring in rat brain areas involved in learning and memory. The compound exerts neuroprotective effects in models of altered cholinergic neurotransmission and of brain vascular injury. In clinical studies choline alphoscerate improved memory and attention impairment, as well as affective and somatic symptoms in dementia disorders. An ongoing trial indicates that association between the acetylcholinesterase inhibitor donepezil and choline alphoscerate is accompanied by an improvement in several cognitive tests superior to that induced by donepezil alone. It is suggested that this association may represent a therapeutic option to prolong beneficial effects of cholinergic therapies in Alzheimer’s disease patients with concomitant ischemic cerebrovascular disorders. In summary, choline alphoscerate has significant effects on cognitive function with a good safety profile and tolerability. Although limited both in terms of size of the samples investigated and of the length of treatment, preclinical and clinical results presented suggest that cognitive enhancing capabilities of choline alphoscerate merit of being further investigated in appropriate trials.

1 January 2010 in Frontiers in Bioscience-Scholar
Verified
Journal Article
Closed access
RARoberto Avola
Roberto Avola
Vincenzo BramantiVincenzo Bramanti
Vincenzo Bramanti
DTDaniele Tomassoni
Daniele Tomassoni
MAMarcello Avitabile
Marcello Avitabile
FAFrancesco Amenta
Francesco Amenta
The two major intermediate filament (IF) proteins of astrocytes are vimentin and GFAP. Early during development, radial glia and immature astrocytes express mainly vimentin. Towards the end of gestation, a switch occurs whereby vimentin is progressively replaced by GFAP in differentiated astroglial cells. The expression of vimentin and GFAP increased markedly after injury to CNS. GFAP has been widely recognized as an astrocyte differentiation marker, constituting the major IF protein of mature astrocyte. In our recent researches we investigated the interactions between growth factors and dexamethasone on cytoskeletal proteins GFAP and vimentin expression under different experimental conditions. In addition, nestin, a currently used marker of neural stem cells, is transiently co-expressed with GFAP during development and is induced in reactive astrocytes following brain injury. The role of S100B in astrocytes, neurons, and microglia is particularly studied in Alzheimer's disease. In conclusion, such glial biomarkers will help us to understand the more general mechanisms involved in CNS development and can open new perspectives for the control of the neurologic diseases.

29 April 2016 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
ASAntonio Salvaggio
Antonio Salvaggio
FMFabio Marino
Fabio Marino
Marco AlbanoMarco Albano
Marco Albano
Roberta PecoraroRoberta Pecoraro
Roberta Pecoraro
GCGiuseppina Camiolo
Giuseppina Camiolo
Maria Violetta BrundoMaria Violetta Brundo
Maria Violetta Brundo
The increase of heavy metals in the environment involves a high exposure of aquatic organisms to these pollutants. The present study is planned to investigate the effects of zinc chloride (ZnCl2) on the bone embryonic development of Danio rerio and confirm the use of zebrafish as a model organism to study the teratogenic potential of this pollutant. zebrafish embryos were exposed to different ZnCl2 concentrations and analyzed by ICP-MS. The skeletal anomalies were evaluated to confocal microscope after staining with calcein solution and RhodZinTM-3,AM. The data show a delay in hatching compared with the controls, malformations in the process of calcification and significant defects in growth. In conclusion, the current work demonstrates for the first time the Zn toxic effects on calcification process and confirm zebrafish (Danio rerio) as suitable alternative vertebrate model to study the causes and the mechanisms of the skeletal malformations.

1 April 2010 in Brain Research
Verified
Journal Article
Closed access
DTDaniele Tomassoni
Daniele Tomassoni
Vincenzo BramantiVincenzo Bramanti
Vincenzo Bramanti
FAFrancesco Amenta
Francesco Amenta

8 July 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CGCesarina Giallongo
Cesarina Giallongo
Alessandra RomanoAlessandra Romano
Alessandra Romano
NPNunziatina Laura Parrinello
Nunziatina Laura Parrinello
PCPiera La Cava
Piera La Cava
Maria Violetta BrundoMaria Violetta Brundo
Maria Violetta Brundo
FRFrancesco Di Raimondo
Francesco Di Raimondo
It is well known that mesenchymal stem cells (MSC) have a role in promotion of tumor growth, survival and drug-resistance in chronic myeloid leukemia (CML). Recent reports indicated that a subpopulation of myeloid cells, defined as granulocyte-like myeloid-derived suppressor cells (G-MDSC) is increased in these patients. So far, the role of MSC in MDSC expansion and activation into the BM microenvironment remains unexplored. To address this question, here we use a specific experimental model in vitro, co-culturing MSC with peripheral blood mononucleated cells (PBMC) from normal individuals, in order to generate MSC-educated G-MDSC. Although MSC of healthy donors (HD) and CML patients were able to generate the same amount of MDSC, only CML-MSC-educated G-MDSC exhibited suppressive ability on autologous T lymphocytes. In addition, compared with HD-MSC, CML-MSC over-expressed some immunomodulatory factors including TGFβ, IL6 and IL10, that could be involved in MDSC activation. CML-MSC-educated G-MDSC expressed higher levels of ARG1, TNFα, IL1β, COX2 and IL6 than G-MDSC isolated from co-culture with HD-MSC. Our data provide evidence that CML-MSC may play a critical role in tumor microenvironment by orchestrating G-MDSC activation and regulating T lymphocytes-mediated leukemia surveillance, thus contributing to CML immune escape.